Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib in HER2-positive breast cancer with brain metastasis
NCT02774681Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Aug 2016
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in HER2-positive breast cancer, brain metastasis (BM), sponsored by Northwestern University. Started Aug 2016; status: terminated.
02
Drugs
palbociclib
03
Conditions
HER2-positive breast cancerbrain metastasis (BM)
Beyond the preview
Go deeper on NCT02774681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02774681.